NEMF

NEMF is the central scaffolding and catalytic subunit of the ribosome-associated quality control (RQC) complex, where it binds stalled 60S ribosomal subunits by simultaneously contacting the ribosome surface and peptidyl-tRNA, thereby sensing nascent-chain occupancy and recruiting the E3 ubiquitin ligase Listerin (LTN1) for ubiquitylation of aberrant translation products (PMID:25578875, PMID:35452614). Independent of Listerin, NEMF appends C-terminal alanine-rich extensions (CAT tails) to stalled nascent chains via tRNA-Ala binding; these tails expose ribosome-buried lysines for ubiquitylation, serve as direct degrons recognized by the CRL2-KLHDC10 and Pirh2 E3 ligases through the C-end rule pathway, direct mitochondrial stalled nascent chains to ClpXP-mediated degradation, and route ER translocon-clogging nonstop substrates through an unconventional ERAD pathway involving Golgi retrieval (PMID:33909987, PMID:38412092, PMID:40257401). When RQC-mediated degradation fails, NEMF-dependent CAT tails promote amyloid-like aggregation of undegraded substrates, and loss-of-function NEMF mutations cause progressive motor neuron degeneration in mice and juvenile neuromuscular disease in humans (PMID:32934225, PMID:26943317). Disease-associated NEMF mutations additionally disrupt Importin-β-dependent nucleocytoplasmic transport with cytoplasmic mislocalization of TDP-43 and nuclear transport factors (PMID:39312574).

1. 2015 High

   Establishing how NEMF senses ribosome-stalled nascent chains and recruits Listerin resolved the fundamental question of how the RQC complex achieves substrate specificity on 60S subunits.

   Evidence Cryo-EM structure at 3.6 Å of the 60S–NEMF–Listerin complex with mutagenesis and in vitro reconstitution

   PMID:25578875

   Open questions at the time

   • Structural basis for tRNA binding by NEMF not resolved in this complex
   • Mechanism of CAT tailing not yet discovered
2. 2016 High

   Discovery that the NEMF ortholog Rqc2 appends untemplated C-terminal Ala/Thr tails to stalled nascent chains revealed a second, Listerin-independent function and linked failed degradation to toxic protein aggregation.

   Evidence Genetic epistasis with Ltn1, detergent-insolubility assays, and in vivo nascent chain labeling in yeast

   PMID:26943317

   Open questions at the time

   • Mammalian CAT tailing not yet demonstrated
   • E3 ligases recognizing CAT tails as degrons not identified
3. 2020 High

   Three independent NEMF-mutant mouse lines developing progressive motor neuron degeneration, together with human family studies, established NEMF as a disease gene and linked impaired CAT tailing to neurodegeneration.

   Evidence Three mouse genetic models, yeast functional validation of orthologous mutations, and exome sequencing of seven human families

   PMID:32934225

   Open questions at the time

   • Cell-type-specific vulnerability of motor neurons not mechanistically explained
   • Whether aggregation or loss of degradation is the primary toxicity driver remained unclear
4. 2020 Medium

   Demonstrating that NEMF knockdown impairs axonal outgrowth and synapse development in primary neurons provided a cellular correlate for the motor neuron disease phenotype.

   Evidence siRNA knockdown in mouse primary cortical neurons with immunofluorescence imaging

   PMID:33048237

   Open questions at the time

   • Single knockdown study without rescue
   • Downstream molecular pathways linking RQC to axonogenesis not identified
5. 2021 High

   Identification of CRL2-KLHDC10 and Pirh2 as E3 ligases that directly bind Ala-tailed substrates established a Listerin-independent, C-end rule degradation pathway downstream of NEMF-mediated CAT tailing.

   Evidence Biochemical pulldowns, in vitro ubiquitination reconstitution, and mutational analysis of the NEMF tRNA-Ala binding domain

   PMID:33909987

   Open questions at the time

   • Relative contributions of C-end rule versus Listerin pathway in different tissues not determined
   • Whether other C-terminal amino acid compositions engage additional E3 ligases unknown
6. 2021 Medium

   Showing that the nascent polypeptide sequence within the exit tunnel determines NEMF dependency for RQC defined substrate-intrinsic determinants that modulate CAT tailing.

   Evidence Yeast in vivo reporter assays for CAT tailing and ubiquitination with polytryptophan sequence variants

   PMID:33511411

   Open questions at the time

   • Rules for mammalian tunnel-sequence effects not tested
   • Structural basis for tunnel-sequence inhibition of CAT tailing not resolved
7. 2024 High

   Discovery that NEMF mediates an organelle-specific mitochondrial RQC pathway, where Ala-tailed mitochondrial nascent chains are cleared by Pirh2 and ClpXP protease, extended the CAT tail degron concept to organelle-targeted substrates.

   Evidence Co-immunoprecipitation, mitochondrial fractionation, in vivo reporters, and NEMF mutant analysis

   PMID:38412092

   Open questions at the time

   • How Ala-tailed substrates are handed off from cytosolic Pirh2 to matrix ClpXP is unclear
   • Whether other mitochondrial proteases contribute is untested
8. 2024 Medium

   NEMF-mutant mouse models revealed that disease-associated mutations disrupt Importin-β nuclear import and cause cytoplasmic TDP-43 mislocalization, connecting RQC failure to nucleocytoplasmic transport defects seen in other neurodegenerative diseases.

   Evidence Co-immunoprecipitation, immunofluorescence, and pharmacological inhibition of Importin-β in two mouse models and human cells

   PMID:39312574

   Open questions at the time

   • Whether nucleocytoplasmic transport disruption is a direct or indirect consequence of RQC failure is unresolved
   • Causal relationship between TDP-43 mislocalization and motor neuron death not established
9. 2025 High

   A genome-wide CRISPR screen revealed that NEMF-mediated CAT tailing is required for translocation-associated quality control at the ER, with AT-rich tails routing nonstop substrates through an unconventional Golgi-retrieval ERAD pathway and AG-rich tails directing substrates to lysosomal degradation.

   Evidence Genome-wide CRISPR screen, live-cell imaging, biochemical degradation assays, and CAT-tail mimetic analysis

   PMID:40257401

   Open questions at the time

   • Receptor(s) that distinguish AT- versus AG-rich tails for routing decisions not identified
   • Whether this pathway operates on endogenous ER-stalled substrates in vivo is untested
10. 2025 High

    A cryo-EM structure of the yeast RQC complex with a disease-relevant Rqc2 mutation elucidated how this mutation disrupts A-site tRNA binding in the presence of Ltn1, mechanistically linking impaired CAT tailing to genetic peptide-release defects.

    Evidence Cryo-EM structure, genetic screen, and functional peptide-release and CAT-tailing assays in yeast

    PMID:40187343

    Open questions at the time

    • Structure of the mammalian NEMF–LTN1 complex at equivalent resolution not yet available
    • Whether peptide release defects contribute to disease pathology in mammals is untested

• Key unresolved questions include why motor neurons are selectively vulnerable to NEMF loss-of-function, whether aggregation toxicity or degradation failure is the primary driver of neurodegeneration, and how CAT tail composition (Ala, Thr, mixed) is decoded by distinct downstream E3 ligases and trafficking pathways to determine substrate fate.
• Tissue-specific proteomics of NEMF-dependent CAT-tailed substrates not performed
• No therapeutic intervention targeting the CAT-tailing or RQC pathway has been reported
• Full mammalian structural model of the NEMF–60S–LTN1–TCF25 complex is lacking